Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Evaluation of Radiotherapy Dose in Secondary Breast Angiosarcoma: Implications for Pathogenesis

SAMULI SALMINEN, LAURA TUOMIKOSKI, MAIJA TARKKANEN, TOM WIKLUND, MIKKO TENHUNEN, RIIKKA NEVALA and MIKA SAMPO
Anticancer Research March 2026, 46 (3) 1517-1522; DOI: https://doi.org/10.21873/anticanres.18046
SAMULI SALMINEN
1Comprehensive Cancer Center, Helsinki University Hospital (HUH), Helsinki, Finland;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: samuli.salminen{at}hus.fi
LAURA TUOMIKOSKI
1Comprehensive Cancer Center, Helsinki University Hospital (HUH), Helsinki, Finland;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MAIJA TARKKANEN
2Finnish Medicines Agency FIMEA and University of Helsinki, Helsinki, Finland;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TOM WIKLUND
3Docrates Cancer Center, Helsinki, Finland;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MIKKO TENHUNEN
1Comprehensive Cancer Center, Helsinki University Hospital (HUH), Helsinki, Finland;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
RIIKKA NEVALA
1Comprehensive Cancer Center, Helsinki University Hospital (HUH), Helsinki, Finland;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MIKA SAMPO
4HUSLAB Pathology and University of Helsinki, Helsinki, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 46 no. 3 1517-1522
DOI 
https://doi.org/10.21873/anticanres.18046
PMID 
41760256

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received December 4, 2025
  • Revision received December 16, 2025
  • Accepted December 17, 2025
  • Published online February 27, 2026.

Copyright & Usage 
Copyright © 2026 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Author Information

  1. SAMULI SALMINEN1⇑,
  2. LAURA TUOMIKOSKI1,
  3. MAIJA TARKKANEN2,
  4. TOM WIKLUND3,
  5. MIKKO TENHUNEN1,
  6. RIIKKA NEVALA1 and
  7. MIKA SAMPO4
  1. 1Comprehensive Cancer Center, Helsinki University Hospital (HUH), Helsinki, Finland;
  2. 2Finnish Medicines Agency FIMEA and University of Helsinki, Helsinki, Finland;
  3. 3Docrates Cancer Center, Helsinki, Finland;
  4. 4HUSLAB Pathology and University of Helsinki, Helsinki, Finland
  1. Samuli Salminen, Comprehensive Cancer Center, PL 180, 00290 Helsinki, Finland. Tel: +35 8401840724, e-mail: samuli.salminen{at}hus.fi
View Full Text

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

Anticancer Research: 46 (3)
Anticancer Research
Vol. 46, Issue 3
March 2026
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Ed Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Evaluation of Radiotherapy Dose in Secondary Breast Angiosarcoma: Implications for Pathogenesis
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
2 + 2 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Evaluation of Radiotherapy Dose in Secondary Breast Angiosarcoma: Implications for Pathogenesis
SAMULI SALMINEN, LAURA TUOMIKOSKI, MAIJA TARKKANEN, TOM WIKLUND, MIKKO TENHUNEN, RIIKKA NEVALA, MIKA SAMPO
Anticancer Research Mar 2026, 46 (3) 1517-1522; DOI: 10.21873/anticanres.18046

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Evaluation of Radiotherapy Dose in Secondary Breast Angiosarcoma: Implications for Pathogenesis
SAMULI SALMINEN, LAURA TUOMIKOSKI, MAIJA TARKKANEN, TOM WIKLUND, MIKKO TENHUNEN, RIIKKA NEVALA, MIKA SAMPO
Anticancer Research Mar 2026, 46 (3) 1517-1522; DOI: 10.21873/anticanres.18046
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Patients and Methods
    • Results
    • Discussion
    • Conclusion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Whole-liver Palliative Radiotherapy Using SIB for Diffuse Liver Metastases: 3D-CRT versus 99mTc-GSA SPECT Image-guided VMAT
  • Real-world Analysis of Treatment Patterns, Clinical Outcomes, and Molecular Profiling in Advanced Biliary Tract Cancer
  • Post-progression Nutritional and Immune Status Determines Survival After First-line Chemotherapy in Unresectable Advanced Gastric Cancer
Show more Clinical Studies

Keywords

  • Breast cancer
  • radiotherapy
  • hemangiosarcoma
  • sarcoma
  • treatment
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire